ArticleObesity surgery2025
Impact of Increasing Robotic Bariatric Utilization on Duodenal Switch Procedure Outcomes.
Article in Obesity surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe growth rate of robotic bariatric surgery has recently increased compared to prior years. The impact of this new growth rate on duodenal switch procedures (DSPs) remains uncertain. MATERIAL AND
methodsDSPs performed using robotic assistance (RDSPs) or conventional laparoscopy (LDSPs) were identified from the 2015 to 2021 Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program (MBSAQIP) databases. Then, 1:1 matched analysis compared outcomes between all RDSPs and LDSPs, and those performed during different operative periods (2015-2018 and 2019-2021).
resultsThen, 14,679 DSPs (73.6% LDSPs and 26.4% RDSPs) were analyzed. Matched analyses compared 2081 RDSPs to 2081 LDSPs. Mean operation length (p < 0.001) and hospital length of stay (LOS) (p < 0.001) were longer for RDSPs. The risk of surgical site infection (SSI) (OR 1.37), readmission (OR 1.34), reintervention (OR 1.39), and overall morbidity (OR 1.34) were significantly higher for RDSPs. RDSPs performed between 2015 and 2018 also had longer operative duration and hospital length of stay, but comparable outcomes to LDSPs. In contrast, RDSPs performed from 2019 to 2021 had higher SSI (OR 1.81), readmission (OR 2.02), reintervention (OR 2.08), and overall morbidity (OR 1.8) risk. Operation duration also remains longer for RDSPs, but similar hospital length of stay.
conclusionIn this matched analysis, both RDSPs and LDSPs were safe. With bariatric growth, more recently performed RDSPs appear to be associated with an increase in some adverse outcomes.
Indexed as
Identifiers
41045419What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.